Sanofi and @GSK have signed a Statement of Intent with the @gavi @WHO @CEPIvaccines #COVAX facility to secure the distribution of our #COVID19 vaccine worldwide: sanofi.com/en/media-room/… #SanofiActs pic.twitter.com/BXD2sLoh0h

.@Sanofi & @GSK have signed a Statement of Intent with @Gavi to make available 200 million doses of their adjuvanted recombinant protein-based #COVID19 vaccine, if approved by regulatory authorities and subject to contract, to the #COVAX Facility.